|
시장보고서
상품코드
1609665
일본의 체외진단(IVD) 시장 보고서 : 검사 유형, 제품, 유용성, 용도, 최종사용자, 지역별(2025-2033년)Japan In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2025-2033 |
||||||
일본의 체외진단(IVD) 시장 규모는 2024년 50억 달러로 추정됩니다. 향후 IMARC 그룹은 2033년까지 시장 규모가 62억 1,000만 달러에 달하고, 2025년부터 2033년까지 2.4%의 연평균 성장률(CAGR)을 나타낼 것으로 예측했습니다. 노인 인구 증가, 급속한 기술 발전, 헬스케어에 대한 인식 증가, 정부 이니셔티브 증가, 맞춤형 약물 요법 개발, 연구개발(R&D) 활동 강화 등이 시장을 이끄는 주요 요인으로 꼽힙니다.
본 보고서에서 다룬 주요 질문
- 일본 체외진단(IVD) 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 발전할 것인가?
- 코로나19가 일본 체외진단(IVD) 시장에 미친 영향은?
- 일본 체외진단(IVD) 시장의 검사 유형별 분석은?
- 일본 체외진단(IVD) 시장의 제품별 분석은?
- 일본 체외진단(IVD) 시장의 사용성별 시장 현황은?
- 일본 체외진단(IVD) 시장의 용도는?
- 일본 체외진단(IVD) 시장의 최종 사용자별 분석은?
- 일본 체외진단(IVD) 시장의 가치사슬에는 어떤 단계가 있는가?
- 일본 체외진단(IVD) 시장의 주요 촉진요인과 과제는?
- 일본 체외진단(IVD) 시장 구조와 주요 기업은?
- 일본 체외진단(IVD) 시장의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 일본의 체외진단(IVD) 시장 : 서론
- 개요
- 시장 역학
- 업계 동향
- 경쟁 정보
제5장 일본의 체외진단(IVD) 시장 구도
- 과거 및 현재 시장 동향(2019-2024년)
- 시장 예측(2025-2033년)
제6장 일본의 체외진단(IVD) 시장 : 검사 유형별 분석
- 임상화학
- 분자진단
- 면역진단
- 혈액학
- 기타
제7장 일본의 체외진단(IVD) 시장 : 제품별 분석
- 시약 및 키트
- 기기
제8장 일본의 체외진단(IVD) 시장 : 사용성별 분석
- 일회용 IVD 디바이스
- 재이용 가능한 체외진단용 기기
제9장 일본의 체외진단(IVD) 시장 : 용도별 분석
- 감염증
- 당뇨병
- 암/종양학
- 심장병학
- 자가면역질환
- 신장학
- 기타
제10장 일본의 체외진단(IVD) 시장 : 최종사용자별 분석
- 병원 연구소
- 임상실험실
- POC 검사 센터
- 학술기관
- 환자
- 기타
제11장 일본의 체외진단(IVD) 시장 : 경쟁 구도
- 개요
- 시장 구조
- 시장 기업 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제12장 주요 기업 개요
제13장 일본의 체외진단(IVD) 시장 - 업계 분석
- 성장 촉진요인 및 억제요인과 기회
- Porter의 Five Forces 분석
- 밸류체인 분석
제14장 부록
LSH 24.12.23The Japan in vitro diagnostics market size reached USD 5.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.21 Billion by 2033, exhibiting a growth rate (CAGR) of 2.4% during 2025-2033. The rising geriatric population, rapid technological advancements, growing healthcare awareness, increasing government initiatives, development of personalized medication, enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.
In vitro diagnostics (IVD) is a collection of medical tests performed using biological samples from the human body. These tests detect diseases, infections, and other medical conditions by analyzing blood, urine, or tissue samples outside the living organism. They are utilized in laboratories, hospitals, and specialized clinics and are vital in medical decision-making, patient monitoring, and personalized treatment. The increasing adoption of IVD in healthcare supports early diagnosis and precise treatment, allowing healthcare providers to make informed and timely decisions. As an essential component of modern healthcare systems, IVD contributes to the advancement of preventive and therapeutic care, enhancing overall patient well-being. It also improves healthcare efficiency, promoting early detection and reducing healthcare costs. It is also employed in monitoring chronic illnesses and assisting in therapeutic decision-making.
Japan In Vitro Diagnostics Market Trends:
The rising geriatric population necessitating more comprehensive and routine medical testing is one of the major factors contributing to the market growth. In line with this, the increasing prevalence of age-related diseases, such as diabetes, cardiovascular conditions, and cancer, prompting increased IVD tests to diagnose and manage these ailments, is propelling the market growth. Additionally, rapid technological advancements in IVD that are introducing innovative solutions with higher accuracy and efficiency, such as innovations in molecular diagnostics, point-of-care (POC) testing, and automation technologies, enhancing the precision, speed, and accessibility of IVD tests, are also creating a positive outlook for the market growth. In addition to this, the increasing government initiatives promoting healthcare innovation and the introduction of user-friendly, personalized IVD solutions are also positively impacting the market growth. Moreover, the growing awareness and emphasis on preventive healthcare as consumers are increasingly proactive in managing their health, leading to higher demand for wellness-related diagnostic tests and personalized medicine solutions, is acting as a growth-inducing factor. Furthermore, the sudden shift towards personalized medicine and the development of molecular diagnostics are shaping the future of the IVD market in Japan. Besides this, the increasing focus on research and development (R&D) and partnerships between diagnostics companies and research institutions are providing remunerative growth opportunities for the market. In addition to this, the integration of big data and artificial intelligence (AI) in diagnostics, enhancing analytical capabilities, and personalizing care is providing remunerative opportunities for the market growth.
Japan In Vitro Diagnostics Market Segmentation:
Test Type Insights:
- Clinical Chemistry
- Molecular Diagnostics
- Immunodiagnostics
- Hematology
- Others
Product Insights:
- Reagents and Kits
- Instruments
Usability Insights:
- Disposable IVD Devices
- Reusable IVD Devices
Application Insights:
- Infectious Disease
- Diabetes
- Cancer/Oncology
- Cardiology
- Autoimmune Disease
- Nephrology
- Others
End User Insights:
- Hospitals Laboratories
- Clinical Laboratories
- Point-Of-Care Testing Centers
- Academic Institutes
- Patients
- Others
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan in vitro diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan in vitro diagnostics market?
- What is the breakup of the Japan in vitro diagnostics market on the basis of test type?
- What is the breakup of the Japan in vitro diagnostics market on the basis of product?
- What is the breakup of the Japan in vitro diagnostics market on the basis of usability?
- What is the breakup of the Japan in vitro diagnostics market on the basis of application?
- What is the breakup of the Japan in vitro diagnostics market on the basis of end user?
- What are the various stages in the value chain of the Japan in vitro diagnostics market?
- What are the key driving factors and challenges in the Japan in vitro diagnostics market?
- What is the structure of the Japan in vitro diagnostics market and who are the key players?
- What is the degree of competition in the Japan in vitro diagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan In Vitro Diagnostics Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan In Vitro Diagnostics Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan In Vitro Diagnostics Market - Breakup by Test Type
- 6.1 Clinical Chemistry
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Molecular Diagnostics
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Immunodiagnostics
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Hematology
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
- 6.5 Others
- 6.5.1 Historical and Current Market Trends (2019-2024)
- 6.5.2 Market Forecast (2025-2033)
7 Japan In Vitro Diagnostics Market - Breakup by Product
- 7.1 Reagents and Kits
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
8 Japan In Vitro Diagnostics Market - Breakup by Usability
- 8.1 Disposable IVD Devices
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Reusable IVD Devices
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
9 Japan In Vitro Diagnostics Market - Breakup by Application
- 9.1 Infectious Disease
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Diabetes
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Cancer/Oncology
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
- 9.4 Cardiology
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
- 9.5 Autoimmune Disease
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2019-2024)
- 9.5.3 Market Forecast (2025-2033)
- 9.6 Nephrology
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2019-2024)
- 9.6.3 Market Forecast (2025-2033)
- 9.7 Others
- 9.7.1 Historical and Current Market Trends (2019-2024)
- 9.7.2 Market Forecast (2025-2033)
10 Japan In Vitro Diagnostics Market - Breakup by End User
- 10.1 Hospitals Laboratories
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
- 10.2 Clinical Laboratories
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
- 10.3 Point-of-care Testing Centers
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
- 10.4 Academic Institutes
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2019-2024)
- 10.4.3 Market Forecast (2025-2033)
- 10.5 Patients
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2019-2024)
- 10.5.3 Market Forecast (2025-2033)
- 10.6 Others
- 10.6.1 Historical and Current Market Trends (2019-2024)
- 10.6.2 Market Forecast (2025-2033)
11 Japan In Vitro Diagnostics Market - Competitive Landscape
- 11.1 Overview
- 11.2 Market Structure
- 11.3 Market Player Positioning
- 11.4 Top Winning Strategies
- 11.5 Competitive Dashboard
- 11.6 Company Evaluation Quadrant
12 Profiles of Key Players
- 12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
- 12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
- 12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
- 12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
- 12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events
13 Japan In Vitro Diagnostics Market - Industry Analysis
- 13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
- 13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
- 13.3 Value Chain Analysis
